South Central Section AUA 2014

RNA CCP Score Provides Significant Prognostic Information

Rancho Mirage, CA—In a study conducted by Jack M. Cuzick, PhD, and colleagues at the Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, London, United Kingdom, the researchers found that cell cycle progression (CCP) score can be used to determine which patients with prostate cancer can be safely managed with a conservative policy, thus avoiding radical treatment. Results of ... Read More »

GTx-758 Effective and Well Tolerated

Rancho Mirage, CA—Preliminary findings of a phase II study demonstrated that the majority of patients on an luteinizing hormone-releasing hormone (LHRH) had suboptimal levels of free testosterone (T) that were further lowered by administration of GTx-758 (Capesaris®). Robert H. Getzenberg, PhD, and colleagues presented the results during a poster session at the South Central Section of the American Urological Association ... Read More »

Cycle Cell Progression Score Influences Prostate Cancer Treatment Decisions

Rancho Mirage, CA—The cell cycle progression (CCP) score report adds meaningful information for clinicians making treatment decisions for patients with prostate cancer. That was among the findings of a prospective study conducted by E. David Crawford, MD, and colleagues. Study results were reported during a poster session at the South Central Section of the American Urological Association 93rd Annual Meeting. ... Read More »